Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 215

1.

Drug discovery and development: Role of basic biological research.

Mohs RC, Greig NH.

Alzheimers Dement (N Y). 2017 Nov 11;3(4):651-657. doi: 10.1016/j.trci.2017.10.005. eCollection 2017 Nov. Review.

2.

Randomized controlled trials in mild cognitive impairment: Sources of variability.

Petersen RC, Thomas RG, Aisen PS, Mohs RC, Carrillo MC, Albert MS; Alzheimer's Disease Neuroimaging Initiative (ADNI) and Foundation for NIH (FNIH) Biomarkers Consortium AD MCI Placebo Data Analysis Project Team.

Neurology. 2017 May 2;88(18):1751-1758. doi: 10.1212/WNL.0000000000003907. Epub 2017 Apr 5.

3.

Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?

Khachaturian ZS, Mesulam MM, Mohs RC, Khachaturian AS.

Alzheimers Dement. 2016 Mar;12(3):213-5. doi: 10.1016/j.jalz.2016.02.003. No abstract available.

PMID:
27012483
4.

The Special Topics Section of Alzheimer's & Dementia.

Khachaturian ZS, Mesulam MM, Khachaturian AS, Mohs RC.

Alzheimers Dement. 2015 Nov;11(11):1261-4. doi: 10.1016/j.jalz.2015.10.002. No abstract available.

PMID:
26589667
5.

Standardizing the use of the Continuous Performance Test in schizophrenia research: a validation study.

Kahn PV, Walker TM, Williams TS, Cornblatt BA, Mohs RC, Keefe RS.

Schizophr Res. 2012 Dec;142(1-3):153-8. doi: 10.1016/j.schres.2012.09.009. Epub 2012 Oct 3.

PMID:
23040735
6.

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH.

Alzheimers Dement. 2011 May;7(3):263-9. doi: 10.1016/j.jalz.2011.03.005. Epub 2011 Apr 21.

7.

Revision of the criteria for Alzheimer’s disease: A symposium.

DeKosky ST, Carrillo MC, Phelps C, Knopman D, Petersen RC, Frank R, Schenk D, Masterman D, Siemers ER, Cedarbaum JM, Gold M, Miller DS, Morimoto BH, Khachaturian AS, Mohs RC.

Alzheimers Dement. 2011 Jan;7(1):e1-12.

PMID:
21322828
8.

Developing a national strategy to prevent dementia: Leon Thal Symposium 2009.

Khachaturian ZS, Barnes D, Einstein R, Johnson S, Lee V, Roses A, Sager MA, Shankle WR, Snyder PJ, Petersen RC, Schellenberg G, Trojanowski J, Aisen P, Albert MS, Breitner JC, Buckholtz N, Carrillo M, Ferris S, Greenberg BD, Grundman M, Khachaturian AS, Kuller LH, Lopez OL, Maruff P, Mohs RC, Morrison-Bogorad M, Phelps C, Reiman E, Sabbagh M, Sano M, Schneider LS, Siemers E, Tariot P, Touchon J, Vellas B, Bain LJ.

Alzheimers Dement. 2010 Mar;6(2):89-97. doi: 10.1016/j.jalz.2010.01.008.

9.

Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.

Mohs RC, Shiovitz TM, Tariot PN, Porsteinsson AP, Baker KD, Feldman PD.

Am J Geriatr Psychiatry. 2009 Sep;17(9):752-9. doi: 10.1097/JGP.0b013e3181aad585.

PMID:
19700948
10.

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.

Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, Deves A, Ferris S, Greenberg BD, Johnson C, Kukull WA, Poirier J, Schenk D, Thies W, Gauthier S, Gilman S, Bernick C, Cummings JL, Fillit H, Grundman M, Kaye J, Mucke L, Reisberg B, Sano M, Pickeral O, Petersen RC, Mohs RC, Carrillo M, Corey-Bloom JP, Foster NL, Jacobsen S, Lee V, Potter WZ, Sabbagh MN, Salmon D, Trojanowski JQ, Wexler N, Bain LJ.

Alzheimers Dement. 2009 Mar;5(2):85-92. doi: 10.1016/j.jalz.2009.01.021.

11.

A perspective on risks that impede development of drugs to modify the course of Alzheimer's disease: can they be reduced?

Mohs RC.

Alzheimers Dement. 2008 Jan;4(1 Suppl 1):S85-7. doi: 10.1016/j.jalz.2007.11.011. Epub 2007 Dec 21. Review.

PMID:
18632007
12.

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years.

Fillenbaum GG, van Belle G, Morris JC, Mohs RC, Mirra SS, Davis PC, Tariot PN, Silverman JM, Clark CM, Welsh-Bohmer KA, Heyman A.

Alzheimers Dement. 2008 Mar;4(2):96-109. doi: 10.1016/j.jalz.2007.08.005.

13.

Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial.

Raskin J, Wiltse CG, Siegal A, Sheikh J, Xu J, Dinkel JJ, Rotz BT, Mohs RC.

Am J Psychiatry. 2007 Jun;164(6):900-9.

PMID:
17541049
14.

AMPA potentiator treatment of cognitive deficits in Alzheimer disease.

Chappell AS, Gonzales C, Williams J, Witte MM, Mohs RC, Sperling R.

Neurology. 2007 Mar 27;68(13):1008-12.

PMID:
17389305
15.

Optimal design of clinical trials for drugs designed to slow the course of Alzheimer's disease.

Mohs RC, Kawas C, Carrillo MC.

Alzheimers Dement. 2006 Jul;2(3):131-9. doi: 10.1016/j.jalz.2006.04.003.

PMID:
19595870
16.

Commentary on "Diagnosis of Alzheimer's disease: two decades of progress".

Mohs RC.

Alzheimers Dement. 2005 Oct;1(2):116-7. doi: 10.1016/j.jalz.2005.09.003. No abstract available.

PMID:
19595839
17.

Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.

Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J, Purohit DP, Perl DP, Davidson M, Mohs RC, Haroutunian V.

J Gerontol A Biol Sci Med Sci. 2005 Apr;60(4):471-5.

18.
19.

Neuropsychological test performance in healthy volunteers before and after donepezil administration.

Beglinger LJ, Gaydos BL, Kareken DA, Tangphao-Daniels O, Siemers ER, Mohs RC.

J Psychopharmacol. 2004 Mar;18(1):102-8.

PMID:
15107192
20.

Cognitive assessment of geriatric schizophrenic patients with severe impairment.

Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Mohs RC, Davis KL.

Arch Clin Neuropsychol. 2002 Oct;17(7):611-23.

PMID:
14591846
21.

Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale.

Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M.

Schizophr Bull. 2003;29(1):45-55.

PMID:
12908660
22.

Striatal size, glucose metabolic rate, and verbal learning in normal aging.

Brickman AM, Buchsbaum MS, Shihabuddin L, Hazlett EA, Borod JC, Mohs RC.

Brain Res Cogn Brain Res. 2003 Jun;17(1):106-16.

PMID:
12763197
23.

Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.

Serby M, Brickman AM, Haroutunian V, Purohit DP, Marin D, Lantz M, Mohs RC, Davis KL.

Am J Geriatr Psychiatry. 2003 May-Jun;11(3):371-4.

PMID:
12724118
24.

Familial patterns of risk in very late-onset Alzheimer disease.

Silverman JM, Smith CJ, Marin DB, Mohs RC, Propper CB.

Arch Gen Psychiatry. 2003 Feb;60(2):190-7.

PMID:
12578437
25.

Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.

Parvathy S, Davies P, Haroutunian V, Purohit DP, Davis KL, Mohs RC, Park H, Moran TM, Chan JY, Buxbaum JD.

Arch Neurol. 2001 Dec;58(12):2025-32. Erratum in: Arch Neurol 2002 Feb;59(2):202.

PMID:
11735776
26.

Current concepts in mild cognitive impairment.

Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B.

Arch Neurol. 2001 Dec;58(12):1985-92. Review.

PMID:
11735772
27.

Reliability and validity of a chronic care facility adaptation of the Clinical Dementia Rating scale.

Marin DB, Flynn S, Mare M, Lantz M, Hsu MA, Laurans M, Paredes M, Shreve T, Zaklad GR, Mohs RC.

Int J Geriatr Psychiatry. 2001 Aug;16(8):745-50.

PMID:
11536340
28.

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients.

Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, Pratt RD; "312" Study Group.

Neurology. 2001 Aug 14;57(3):481-8. Erratum in: Neurology 2001 Nov 27;57(10):1942.

PMID:
11502917
29.

Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL.

Neurology. 2001 May 8;56(9):1154-66.

PMID:
11342679
30.

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.

Ho L, Purohit D, Haroutunian V, Luterman JD, Willis F, Naslund J, Buxbaum JD, Mohs RC, Aisen PS, Pasinetti GM.

Arch Neurol. 2001 Mar;58(3):487-92.

PMID:
11255454
31.

Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.

Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP.

Ann Neurol. 2000 Sep;48(3):297-303.

PMID:
10976635
32.

Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.

Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL.

Arch Neurol. 2000 Aug;57(8):1145-50.

PMID:
10927794
33.

Has familial aggregation in Alzheimer's disease been overestimated?

Silverman JM, Smith CM, Marin DB, Schmeidler J, Birstein S, Lantz M, Davis KL, Mohs RC.

Int J Geriatr Psychiatry. 2000 Jul;15(7):631-7.

PMID:
10918344
34.

No support for linkage to the bipolar regions on chromosomes 4p, 18p, or 18q in 43 schizophrenia pedigrees.

Nancarrow DJ, Levinson DF, Taylor JM, Hayward NK, Walters MK, Lennon DP, Nertney DA, Jones HL, Mahtani MM, Kirby A, Kruglyak L, Brown DM, Crowe RR, Andreasen NC, Black DW, Silverman JM, Mohs RC, Siever LJ, Endicott J, Sharpe L, Mowry BJ.

Am J Med Genet. 2000 Apr 3;96(2):224-7. No abstract available.

PMID:
10893501
35.

Longitudinal studies of cognitive, functional and behavioural change in patients with Alzheimer's disease.

Mohs RC, Schmeidler J, Aryan M.

Stat Med. 2000 Jun 15-30;19(11-12):1401-9. Review.

PMID:
10844705
36.

Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas.

Harvey PD, Moriarty PJ, Friedman JI, White L, Parrella M, Mohs RC, Davis KL.

Biol Psychiatry. 2000 Jun 1;47(11):962-8.

PMID:
10838064
37.

Visuospatial working memory in schizotypal personality disorder patients.

Roitman SE, Mitropoulou V, Keefe RS, Silverman JM, Serby M, Harvey PD, Reynolds DA, Mohs RC, Siever LJ.

Schizophr Res. 2000 Feb 14;41(3):447-55.

PMID:
10728721
38.

Neuropeptide abnormalities in patients with early Alzheimer disease.

Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V.

Arch Gen Psychiatry. 1999 Nov;56(11):981-7.

PMID:
10565496
39.

Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease.

Ehrenkrantz D, Silverman JM, Smith CJ, Birstein S, Marin D, Mohs RC, Davis KL.

Am J Med Genet. 1999 Aug 20;88(4):378-82.

PMID:
10402505
40.

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.

Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC.

Arch Neurol. 1999 Jun;56(6):713-8.

PMID:
10369312
41.

The impact of behavioral impairment of functional ability in Alzheimer's disease.

Green CR, Marin DB, Mohs RC, Schmeidler J, Aryan M, Fine E, Davis KL.

Int J Geriatr Psychiatry. 1999 Apr;14(4):307-16.

PMID:
10340193
42.

Cholinergic markers in elderly patients with early signs of Alzheimer disease.

Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V.

JAMA. 1999 Apr 21;281(15):1401-6.

PMID:
10217056
43.

Identifying families with likely genetic protective factors against Alzheimer disease.

Silverman JM, Smith CJ, Marin DB, Birstein S, Mare M, Mohs RC, Davis KL.

Am J Hum Genet. 1999 Mar;64(3):832-8.

44.

Convergence of cognitive and adaptive decline in late-life schizophrenia.

Harvey PD, Parrella M, White L, Mohs RC, Davidson M, Davis KL.

Schizophr Res. 1999 Jan 4;35(1):77-84.

PMID:
9988843
45.

Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population.

Sheu KF, Brown AM, Haroutunian V, Kristal BS, Thaler H, Lesser M, Kalaria RN, Relkin NR, Mohs RC, Lilius L, Lannfelt L, Blass JP.

Ann Neurol. 1999 Jan;45(1):48-53.

PMID:
9894876
46.

Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients.

Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, Davidson M, Davis KL.

Biol Psychiatry. 1999 Jan 1;45(1):32-40.

PMID:
9894573
47.

Age-related shift in brain region activity during successful memory performance.

Hazlett EA, Buchsbaum MS, Mohs RC, Spiegel-Cohen J, Wei TC, Azueta R, Haznedar MM, Singer MB, Shihabuddin L, Luu-Hsia C, Harvey PD.

Neurobiol Aging. 1998 Sep-Oct;19(5):437-45.

PMID:
9880046
48.

Verbal learning and memory in schizotypal personality disorder.

Bergman AJ, Harvey PD, Roitman SL, Mohs RC, Marder D, Silverman JM, Siever LJ.

Schizophr Bull. 1998;24(4):635-41.

PMID:
9853795
49.

Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease.

Schmeidler J, Mohs RC, Aryan M.

Alzheimer Dis Assoc Disord. 1998 Sep;12(3):146-51.

PMID:
9772016
50.

Supplemental Content

Support Center